|The potential of anti-malarial compounds derived from African medicinal plants. Part I: A pharmacological evaluation of alkaloids and terpenoids|
PA Onguéné, F Ntie-Kang, LL Lifongo, JC Ndom, W Sippl, LM Mbaze
Malaria Journal 12 (1), 449, 2013
|AfroDb: a select highly potent and diverse natural product library from African medicinal plants|
F Ntie-Kang, D Zofou, SB Babiaka, R Meudom, M Scharfe, LL Lifongo, ...
PloS one 8 (10), e78085, 2013
|The potential of anti-malarial compounds derived from African medicinal plants, part II: a pharmacological evaluation of non-alkaloids and non-terpenoids|
F Ntie-Kang, PA Onguéné, LL Lifongo, JC Ndom, W Sippl, LM Mbaze
Malaria journal 13 (1), 81, 2014
|Cameroonian medicinal plants: a bioactivity versus ethnobotanical survey and chemotaxonomic classification|
F Ntie-Kang, LL Lifongo, LM Mbaze, N Ekwelle, LCO Owono, ...
BMC complementary and alternative medicine 13 (1), 147, 2013
|Molecular modeling of potential anticancer agents from African medicinal plants|
F Ntie-Kang, JN Nwodo, A Ibezim, CV Simoben, B Karaman, VF Ngwa, ...
Journal of chemical information and modeling 54 (9), 2433-2450, 2014
|An in silico evaluation of the ADMET profile of the StreptomeDB database|
SpringerPlus 2 (1), 353, 2013
|Bioactive natural products derived from the Central African flora against neglected tropical diseases and HIV|
D Zofou, F Ntie-Kang, W Sippl, SMN Efange
Natural Product Reports 30 (8), 1098-1120, 2013
|The value of pyrans as anticancer scaffolds in medicinal chemistry|
D Kumar, P Sharma, H Singh, K Nepali, GK Gupta, SK Jain, F Ntie-Kang
RSC advances 7 (59), 36977-36999, 2017
|CamMedNP: building the Cameroonian 3D structural natural products database for virtual screening|
F Ntie-Kang, JA Mbah, LM Mbaze, LL Lifongo, M Scharfe, JN Hanna, ...
BMC complementary and alternative medicine 13 (1), 1-10, 2013
|A Bioactivity Versus Ethnobotanical Survey of Medicinal Plants from Nigeria, West Africa|
LL Lifongo, CV Simoben, F Ntie-Kang, SB Babiaka, PN Judson
Natural Products and Bioprospecting 4 (1), 1-19, 2014
|In silico drug metabolism and pharmacokinetic profiles of natural products from medicinal plants in the Congo basin|
F Ntie-Kang, LL Lifongo, JA Mbah, LCO Owono, E Megnassan, LM Mbaze, ...
In silico pharmacology 1 (1), 12, 2013
|Anti-trypanosomal activity of Nigerian plants and their constituents|
NJ Nwodo, A Ibezim, F Ntie-Kang, MU Adikwu, CJ Mbah
Molecules 20 (5), 7750-7771, 2015
|NANPDB: a resource for natural products from northern African sources|
F Ntie-Kang, KK Telukunta, K Döring, CV Simoben, AF A. Moumbock, ...
Journal of natural products 80 (7), 2067-2076, 2017
|Composite SERS-based satellites navigated by optical tweezers for single cell analysis|
IY Stetciura, A Yashchenok, A Masic, EV Lyubin, OA Inozemtseva, ...
Analyst 140 (15), 4981-4986, 2015
|Virtualizing the p-ANAPL library: a step towards drug discovery from African medicinal plants|
F Ntie-Kang, PA Onguene, GW Fotso, K Andrae-Marobela, M Bezabih, ...
PLoS One 9 (3), e90655, 2014
|ConMedNP: a natural product library from Central African medicinal plants for drug discovery|
F Ntie-Kang, PA Onguéné, M Scharfe, LCO Owono, E Megnassan, ...
Rsc Advances 4 (1), 409-419, 2014
|Exploring cancer therapeutics with natural products from African medicinal plants, part II: alkaloids, terpenoids and flavonoids|
J N Nwodo, A Ibezim, CV Simoben, F Ntie-Kang
Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal …, 2016
|Control of malaria and other vector-borne protozoan diseases in the tropics: enduring challenges despite considerable progress and achievements|
D Zofou, RB Nyasa, DS Nsagha, F Ntie-Kang, HD Meriki, JCN Assob, ...
Infectious diseases of poverty 3 (1), 1, 2014
|The potential of anti-malarial compounds derived from African medicinal plants, part III: an in silico evaluation of drug metabolism and pharmacokinetics profiling|
PA Onguéné, F Ntie-Kang, JA Mbah, LL Lifongo, JC Ndom, W Sippl, ...
Organic and medicinal chemistry letters 4 (1), 6, 2014
|Screening of the Pan-African Natural Product library identifies ixoratannin A-2 and boldine as novel HIV-1 inhibitors|
I Tietjen, F Ntie-Kang, P Mwimanzi, PA Onguéné, MA Scull, TO Idowu, ...
PLoS One 10 (4), e0121099, 2015